Sun M, Monahan K, Moquet J, Barnard S
Cancers (Basel). 2025; 17(4).
PMID: 40002162
PMC: 11852753.
DOI: 10.3390/cancers17040564.
Llargues-Sistac G, Bonjoch L, Munoz J, Dominguez-Rovira X, Ocana T, Alvarez-Mora M
NPJ Genom Med. 2025; 10(1):3.
PMID: 39821083
PMC: 11739559.
DOI: 10.1038/s41525-025-00462-y.
Eikenboom E, Nasar N, Seier K, Gonen M, Spaander M, OReilly E
Ann Surg Oncol. 2024; .
PMID: 39656390
DOI: 10.1245/s10434-024-16621-x.
Faizee M, Talib N, Hamdan A, Abdullah N, Rahimi B, Haidary A
Diagn Pathol. 2024; 19(1):155.
PMID: 39609863
PMC: 11606071.
DOI: 10.1186/s13000-024-01571-5.
Nowak M, Jabbar F, Rodewald A, Gneo L, Tomasevic T, Harkin A
Cell Rep Med. 2024; 5(9):101727.
PMID: 39293403
PMC: 11525017.
DOI: 10.1016/j.xcrm.2024.101727.
Prime Editing and DNA Repair System: Balancing Efficiency with Safety.
Daliri K, Hescheler J, Pfannkuche K
Cells. 2024; 13(10.
PMID: 38786078
PMC: 11120019.
DOI: 10.3390/cells13100858.
Clinicopathological characteristics of Lynch-like syndrome.
Nakamori S, Takao M, Takao A, Natsume S, Iijima T, Kojika E
Int J Clin Oncol. 2024; 29(7):944-952.
PMID: 38642190
DOI: 10.1007/s10147-024-02527-x.
Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome.
Ito T, Yamaguchi T, Kumamoto K, Suzuki O, Chika N, Kawakami S
Int J Clin Oncol. 2024; 29(7):953-963.
PMID: 38615286
PMC: 11196295.
DOI: 10.1007/s10147-024-02518-y.
Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T, Huang X, Liu W, Ling X, Su Z, Huang M
Diagn Pathol. 2024; 19(1):25.
PMID: 38297350
PMC: 10829171.
DOI: 10.1186/s13000-024-01447-8.
DNA Mismatch Repair Gene Variant Classification: Evaluating the Utility of Somatic Mutations and Mismatch Repair Deficient Colonic Crypts and Endometrial Glands.
Walker R, Mahmood K, Como J, Clendenning M, Joo J, Georgeson P
Cancers (Basel). 2023; 15(20).
PMID: 37894291
PMC: 10605939.
DOI: 10.3390/cancers15204925.
Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer.
Song Y, Kerr T, Sanders C, Dai L, Baxter S, Somerville B
Front Oncol. 2023; 13:1223915.
PMID: 37746286
PMC: 10516605.
DOI: 10.3389/fonc.2023.1223915.
PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer.
Sandoval R, Horiguchi M, Ukaegbu C, Furniss C, Uno H, Syngal S
Fam Cancer. 2023; 22(4):459-465.
PMID: 37572151
DOI: 10.1007/s10689-023-00345-0.
Lynch syndrome-associated endometrial cancer patient with a rare novel germline likely pathogenic variant of MSH2 gene: A case report.
Zumstein L, Tuninetti V, Vaira M, Siatis D, Palermo F, Petracchini M
Gynecol Oncol Rep. 2023; 48:101220.
PMID: 37434947
PMC: 10331303.
DOI: 10.1016/j.gore.2023.101220.
Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from Colorectal Cancer.
Greco L, Rubbino F, Dal Buono A, Laghi L
Genes (Basel). 2023; 14(6).
PMID: 37372349
PMC: 10298406.
DOI: 10.3390/genes14061169.
Explore the dominant factor in prime editing via a view of DNA processing.
Xu Z, Ma D, Su H, Jia X, Li Y, Lu Y
Synth Syst Biotechnol. 2023; 8(3):371-377.
PMID: 37325180
PMC: 10265487.
DOI: 10.1016/j.synbio.2023.05.007.
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.
Walker R, Mahmood K, Joo J, Clendenning M, Georgeson P, Como J
J Transl Med. 2023; 21(1):282.
PMID: 37101184
PMC: 10134620.
DOI: 10.1186/s12967-023-04143-1.
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.
Walker R, Mahmood K, Joo J, Clendenning M, Georgeson P, Como J
medRxiv. 2023; .
PMID: 36909643
PMC: 10002795.
DOI: 10.1101/2023.02.27.23285541.
Discordance between germline genetic findings and abnormal tumor immunohistochemistry staining of mismatch repair proteins in individuals with suspected Lynch syndrome.
Pan S, Cox H, Willmott J, Mundt E, Gorringe H, Landon M
Front Oncol. 2023; 13:1069467.
PMID: 36793599
PMC: 9923021.
DOI: 10.3389/fonc.2023.1069467.
Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test?.
Rebuzzi F, Ulivi P, Tedaldi G
Int J Mol Sci. 2023; 24(3).
PMID: 36768460
PMC: 9916931.
DOI: 10.3390/ijms24032137.
Functional characterization of MLH1 missense variants unveils mechanisms of pathogenicity and clarifies role in cancer.
Mahdouani M, Ben Ahmed S, Hmila F, Rais H, Ben Sghaier R, Saad H
PLoS One. 2022; 17(12):e0278283.
PMID: 36454741
PMC: 9714755.
DOI: 10.1371/journal.pone.0278283.